Targeting the gut-vascular axis: Chondroitin sulfate C enhances microbial hydrogen sulfide production to alleviate hypertension
International Journal of Biological Macromolecules · 2026
DOI: 10.1016/j.ijbiomac.2025.149727 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Macromolecules, 2026. Verfasst von Naishi Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Academy of Agricultural Sciences (Northeast Agricultural Research Center of China), Changchun, 130033, PR China. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Gastrointestinal Microbiome, Hypertension, Chondroitin Sulfates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Earmarked Fund for China Agriculture Research System.
Abstract (Originalsprache)
Hypertension remains a major global health challenge, often associated with vascular remodeling, oxidative stress, inflammation, and gut microbiota dysbiosis. In this study, we explored the effects of chondroitin sulfate C, a special bioactive substance, on blood pressure regulation and its potential mechanism involving the gut-vascular axis. Hypertensive rats induced by L-NAME were treated with chondroitin sulfate C, which resulted in significant reductions in both systolic and diastolic blood pressure, as well as improvements in aortic histology. Mechanistically, chondroitin sulfate C mitigated oxidative stress, as evidenced by increased antioxidant enzyme activity and decreased ROS production. Inflammatory markers, including TNF-α and adhesion molecules, were significantly reduced. Notably, chondroitin sulfate C promoted the growth of Desulfovibrio in the gut, leading to increased H2S production, which activated the AKT/eNOS pathway, restored NO levels, and enhanced vasodilation. These findings suggest that gut-derived H2S plays a critical role in blood pressure regulation and highlight the therapeutic potential of chondroitin sulfate C in hypertension management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jilin Academy of Agricultural Sciences (Northeast Agricultural Research Center of China), Changchun, 130033, PR China.
- Jilin Academy of Agricultural Sciences (Northeast Agricultural Research Center of China), Changchun, 130033, PR China; State Key Laboratory of Food Science and Technology, School of Food Science and Technology, National…
- Jilin Province Animal Husbandry and Veterinary Academy of Sciences, Changchun, 130000, PR China.
- Jilin Academy of Agricultural Sciences (Northeast Agricultural Research Center of China), Changchun, 130033, PR China. Electronic address: zhaojaas@163.com.
Förderung
- Earmarked Fund for China Agriculture Research System
Zitieren
APA
Chen, N., Ma, L., Kang, Y., Quan, X., Zhao, Y., Yang, G., Gao, Y., Li, S., & Zhao, Z. (2026). Targeting the gut-vascular axis: Chondroitin sulfate C enhances microbial hydrogen sulfide production to alleviate hypertension. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2025.149727
Vancouver
Chen N, Ma L, Kang Y, Quan X, Zhao Y, Yang G, et al. Targeting the gut-vascular axis: Chondroitin sulfate C enhances microbial hydrogen sulfide production to alleviate hypertension. International Journal of Biological Macromolecules. 2026. doi:10.1016/j.ijbiomac.2025.149727
BibTeX
@article{Chen2026,
author = {Chen, Naishi and Ma, Liying and Kang, You and Quan, Xinjiao and Zhao, Yujuan and Yang, Ge and Gao, Yansong and Li, Shengyu and Zhao, Zijian},
title = {Targeting the gut-vascular axis: Chondroitin sulfate C enhances microbial hydrogen sulfide production to alleviate hypertension},
journal = {International Journal of Biological Macromolecules},
year = {2026},
doi = {10.1016/j.ijbiomac.2025.149727}
}
EUVIMED